|Day Low/High||3.41 / 3.56|
|52 Wk Low/High||1.97 / 6.20|
Conference Call Scheduled for Monday, November 17, 2014 at 8:30am Eastern / 5:30am Pacific
New Patents Provide Additional Coverage for Lead Product Candidates FMX101, FMX102, and FDX104
These under-$10 stocks look ready to trade higher from current levels.
Foam Based Topical Formulation of Doxycycline is Being Developed to Treat the Most Common Side Effect of EGFRI Anti-Cancer Agents
Shares of Foamix Pharmaceuticals (FOMX) soared in morning trading Thursday after the company announced the pricing of its IPO.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.